within Pharmacolibrary.Drugs.ATC.H;

model H01BA02
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 0.00012666666666666666,
    adminDuration  = 600,
    adminMass      = 0.3 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.048299999999999996,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>H01BA02</td></tr><td>route:</td><td>intranasal</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Desmopressin is a synthetic analogue of the natural pituitary hormone vasopressin. It is primarily used in the treatment of diabetes insipidus, nocturnal enuresis, and certain bleeding disorders such as hemophilia A and von Willebrand's disease. The drug is approved and widely used today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers after intranasal administration.</p><h4>References</h4><ol><li><p>Katare, YK, et al., &amp; Mishra, RK (2017). Intranasal delivery of antipsychotic drugs. <i>Schizophrenia research</i> 184 2–13. DOI:<a href=\"https://doi.org/10.1016/j.schres.2016.11.027\">10.1016/j.schres.2016.11.027</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/27913162/\">https://pubmed.ncbi.nlm.nih.gov/27913162</a></p></li><li><p>Lethagen, S, et al., &amp; Nilsson, IM (1987). Intranasal and intravenous administration of desmopressin: effect on F VIII/vWF, pharmacokinetics and reproducibility. <i>Thrombosis and haemostasis</i> 58(4) 1033–1036. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/3127915/\">https://pubmed.ncbi.nlm.nih.gov/3127915</a></p></li><li><p>Fortuna, A, et al., &amp; Falcão, A (2014). Intranasal delivery of systemic-acting drugs: small-molecules and biomacromolecules. <i>European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V</i> 88(1) 8–27. DOI:<a href=\"https://doi.org/10.1016/j.ejpb.2014.03.004\">10.1016/j.ejpb.2014.03.004</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/24681294/\">https://pubmed.ncbi.nlm.nih.gov/24681294</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end H01BA02;
